Please login to the form below

Not currently logged in
Email:
Password:

PRA expands its European operations with new UK and Dutch offices

Will open new base in Utrecht and relocate its existing Reading, UK offices to a larger site

PRA is expanding its European operations and plans to open a new base in Utrecht in the Netherlands and relocate its existing Reading, UK office to a larger site.

The contract research organisation's (CRO) new Dutch facility will be home to over 20 employees and primarily support product registration trials – the first PRA office to have this focus.

The company's product registration staff had previously been either home-based or have shared facilities with colleagues based in Mechelen in Belgium.

“But to better share best practices among employees, we felt that it was now necessary to provide a permanent office for the increasing Dutch product registration team,” said PRA's Frank van de Wijngaert, vice president and general partner.

Meanwhile, PRA is also relocating over 240 employees based in Reading in the UK to a larger purpose build facility that offers additional room for increasing headcounts and provides modern facilities for client and project team meetings.

The CRO has recently signed a number of major deals, including a biosimilar research agreement with Amgen and global drug development partnership with UCB, and has been expanding of late.

PRA has opened nine new offices in Europe since 2009, including a Romanian base in August 2011, and it also opened new Singapore offices earlier this year.

22nd May 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics